Contemporary Operator Procedural Volumes and Outcomes for TAVR and MTEER in the US

Heart, Artery and Coronary DiseasesTherapy and Intervention

Contemporary Incidence and Procedural Volume of Transcatheter Aortic Valve Reintervention

JAMA Cardiol

Braasch MC, Pyeatte SR, He J, Rahimi M, Brescia AA, Kachroo P, Roberts HG Jr, Frogge N, Quader N, Sintek MA, Zajarias A, Kouchoukos N, Kaneko T

doi: 10.1001/jamacardio.2025.3224

Heart, Artery and Coronary Diseases

Institutional Variability in Processes of Care and Outcomes Among Patients With STEMI in the US

JAMA Cardiol

Sammour YM, Khan SU, Hong H, Wu J, Fanaroff AC, Reed GW, Poudel R, Thomas K, Ni Z, Goyal A, Kirtane AJ, Yeh RW, Jones WS, Goel SS, Jaber WA, Kleiman NS

doi: 10.1001/jamacardio.2025.1411

Heart Failure

Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial

PLoS One

Bitos K, Laptseva N, Haider T, Rossi VA, Nägele MP, Barthelmes J, Ruschitzka F, Sudano I, Flammer AJ

doi: 10.1371/journal.pone.0325668

Hypertension

Contemporary Prevalence and Treatment Patterns Among US Adults With Apparent Treatment-Resistant Hypertension

Hypertension

Earle WB, Watson NW, Juraschek SP, Cluett JL, Krawisz AK, Secemsky EA

doi: 10.1161/HYPERTENSIONAHA.125.25659

Heart Failure

Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials

JACC Heart Fail

Lassen MCH, Ostrominski JW, Claggett BL, Neuen BL, Beldhuis IE, Butt J, Biering-Sørensen T, Desai AS, Lewis EF, Jhund PS, Mc Causland F, Anand IS, Pfeffer MA, Pitt B, Zannad F, Zile MR, McMurray JJV, Solomon SD, Vaduganathan M

doi: 10.1016/j.jchf.2025.03.042

Cardiovascular Risk and Diseases

Extra-Virgin Olive Oil and Additional Cardiovascular Outcomes in the PREDIMED Trial: An Outcome-Wide Perspective

Am Heart J

de Rojas JP, Toledo E, Estruch R, Guasch-Ferré M, Salas-Salvadó J, Gómez-Gracia E, Ros E, Fitó M, Arós F, Fiol M, Lapetra J, Serra-Majem L, Pintó X, Sorlí JV, Babio N, Castañer O, Alonso-Gómez ÁM, Martínez-González MÁ, Jiménez-Moleón JJ

doi: 10.1016/j.ahj.2025.08.021

COMMENTED

Cardiovascular Risk and Diseases

Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol

Vazquez Arreola E, Gong Q, Hanson RL, Wang J, Sandforth L, He S, Sandforth A, Qian X, Giacca M, Bornstein SR, Fritsche A, Stefan N, Preissl H, Gregg EW, Marx N, Jumpertz-von Schwartzenberg R, Li G, Birkenfeld AL

doi: 10.1016/S2213-8587(25)00295-5

Atrial FibrillationThrombosis and Stroke

Long-Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry

J Am Heart Assoc

Higgins AY, Zimmerman S, Wang Y, Friedman DJ, Faridi KF, Price MJ, Reddy VY, Holmes DR Jr, Curtis JP, Freeman JV

doi: 10.1161/JAHA.124.039780

Myocardial Infarction

Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries

Circ Cardiovasc Qual Outcomes

Mentias A, Keshvani N, Desai MY, Kapadia S, Ziada KM, McCarthy CP, Hall HM, Park K, Kumbhani DJ, Lincoff AM, Januzzi JL Jr, Pandey A

doi: 10.1161/CIRCOUTCOMES.125.012136

Related content